Welcome to our dedicated page for INNOSPEC SEC filings (Ticker: IOSP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Innospec Inc. filings document the financial reporting, governance and capital-return disclosures of a specialty chemicals operating company. Form 8-K reports record quarterly and annual results, segment commentary for Performance Chemicals, Fuel Specialties and Oilfield Services, Regulation FD disclosures, semi-annual dividends and board-authorized common stock repurchase programs.
The company’s proxy materials describe annual meeting matters, director elections, executive compensation votes, auditor ratification and related governance procedures. Its filings also identify IOSP common stock as a NASDAQ-listed security and provide formal disclosure around results of operations, financial condition, risk-related business context and shareholder voting matters.
Innospec Inc. reported higher results for the quarter ended June 30, 2026. Net sales rose to $491.4 million from $439.7 million, and net income attributable to Innospec increased to $30.8 million, with diluted EPS of $1.25 versus $0.94 a year earlier.
All three segments grew sales: Performance Chemicals to $190.3 million, Fuel Specialties to $185.7 million, and Oilfield Services to $115.4 million, with Oilfield Services showing the strongest gross margin improvement. Six‑month operating cash flow declined to $24.8 million from $38.8 million, mainly from higher receivables and inventory. Cash and cash equivalents were $250.2 million, and the company had no borrowings under its $250.0 million multicurrency revolving credit facility. Innospec paid $22.7 million in dividends, repurchased $13.5 million of stock, carries plant closure provisions of $64.7 million, and continues to pursue civil and criminal claims related to a prior inventory misappropriation in Brazil with no significant new developments.
Innospec Inc. reported solid second-quarter 2026 results with broad-based growth across all segments. Total revenue was $491.4 million, up 12 percent from $439.7 million a year earlier. Net income attributable to Innospec rose to $30.8 million, and diluted GAAP EPS increased to $1.25 from $0.94. Adjusted non-GAAP EPS was $1.27, slightly above $1.26 last year, while adjusted EBITDA was $50.1 million versus $49.1 million.
Performance Chemicals revenue grew 9 percent to $190.3 million with operating income up 15 percent. Fuel Specialties revenue increased 12 percent to $185.7 million, and Oilfield Services revenue rose 14 percent to $115.4 million, with operating income in that segment up 40 percent. The quarter ended with a debt‑free balance sheet and $250.2 million in cash and cash equivalents. Operating cash flow for the quarter was $7.2 million. Innospec returned capital through a semi‑annual dividend of $0.92 per share (about $22.7 million) and share repurchases of 87,089 shares for $6.4 million.
Allspring Global Investments Holdings, LLC reports beneficial ownership of Innospec Inc common stock on an amended Schedule 13G. The firm and its investment adviser subsidiaries collectively beneficially own 1,892,471 shares, representing 7.7% of the outstanding common stock.
Allspring has sole voting power over 1,891,583 shares and sole dispositive power over 1,892,471 shares, with no shared voting or dispositive power. The securities are held of record by clients of Allspring’s investment advisers, who are entitled to dividends and sale proceeds, but no single client holds more than five percent of the class.
Dimensional Fund Advisors LP reports beneficial ownership of 1,305,038 shares of Innospec Inc. common stock, representing 5.3% of the class as of June 30, 2026. It reports sole voting power over 1,279,717 shares and sole dispositive power over 1,305,038 shares, with no shared voting or dispositive power.
The shares are held by investment companies and other funds for which Dimensional or its subsidiaries act as adviser or manager. Dimensional may be deemed a beneficial owner due to its voting and investment authority but disclaims beneficial ownership, and no individual fund’s interest exceeds 5% of Innospec’s common stock.
INNOSPEC INC. director Shelley J Bausch has filed an initial insider ownership report on Form 3. The filing identifies Bausch as a director and shows no share transactions, holdings, or derivative positions reported in the provided data.
Innospec Inc. reported a change in its Board of Directors. Effective June 2, 2026, the Board increased its size from seven to eight members and appointed Shelley Bausch as a Class II director, starting July 1, 2026 and serving until the 2027 annual stockholder meeting or until a successor is elected and qualified.
She will also join the Audit Committee on July 1, 2026. As a non-employee director, Ms. Bausch will receive a standard annual cash retainer of $100,000, plus an additional annual $5,000 for Audit Committee service, both paid quarterly. She will be eligible for an annual equity grant with an expected value of $125,000 under the company’s Long-Term Incentive Omnibus Plan, similar to awards granted in February 2025, which vest after three years. She may also earn $2,000 per additional day for extra services at the CEO’s request, and the company states there are no related-party transactions requiring disclosure.
Innospec Inc. reported the results of its 2026 Annual Meeting of Stockholders held on May 8, 2026. As of the March 13, 2026 record date, 24,890,467 shares of common stock were outstanding and entitled to vote, and 22,661,185 shares were present or represented by proxy, about 91% of eligible shares.
Stockholders re-elected Class I directors Elizabeth K. Arnold and Claudia P. Poccia. They also approved the advisory vote on executive compensation and ratified the appointment of the company’s independent registered public accounting firm for 2026, based on the final certified vote results.
Innospec Inc. reported first-quarter 2026 revenue of $453.2 million, up 3% from $440.8 million a year earlier, while GAAP diluted EPS declined to $1.22 from $1.31. Adjusted non-GAAP EPS fell to $1.05 from $1.42 as margins weakened in certain segments.
Performance Chemicals revenue rose slightly to $169.4 million, but operating income dropped 46% to $10.7 million, reflecting impacts from a U.S. winter storm. Fuel Specialties delivered another solid quarter with revenue of $181.6 million, up 7%, and operating income of $37.8 million, up 2%. Oilfield Services revenue was stable at $102.2 million, with operating income improving 37% to $5.6 million.
The company ended the quarter with $289.1 million in cash and no debt. The board increased the semi-annual dividend by 10% to $0.92 per share, payable May 29, 2026, and authorized a new $75 million share repurchase program over three years, replacing a prior $50 million authorization.
Innospec Inc reported that Vanguard Capital Management beneficially owned 1,300,194 shares of Common Stock, representing 5.22% of the class as of 03/31/2026. The filing shows Vanguard has sole dispositive power over 1,300,194 shares and sole voting power for 185,596 shares. The Schedule 13G was signed on 04/30/2026.